Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-06 Purchase |
2024-12-10 8:46 pm |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
60,000 | $1.4451 | $86,708 | 652,573 (Indirect) |
View |
| 2024-11-26 Purchase |
2024-11-27 7:07 pm |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
75,000 | $1.4091 | $105,685 | 622,573 (Indirect) |
View |
| 2024-11-19 Purchase |
2024-11-21 6:00 pm |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
200,000 | $1.0656 | $213,128 | 514,788 (Indirect) |
View |
| 2024-01-12 Sale |
2024-01-17 5:03 pm |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
1,425 | $21.91 | $31,229 | 485,073 (Indirect) |
View |
| 2024-01-10 Sale |
2024-01-12 5:08 pm |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
3,669 | $21.93 | $80,443 | 485,792 (Indirect) |
View |
| 2022-03-29 Purchase |
2022-03-31 8:15 pm |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
153,334 | $15 | $2,300,010 | 487,592 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-19 Option Award |
2024-12-23 6:32 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
9,077 | $0 | 1,243,938 (Direct) |
View |
| 2024-06-19 Option Award |
2024-06-21 6:22 pm |
N/A 2034-06-18 |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
64,503 | $0 | 64,503 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 8:33 pm |
N/A 2033-06-06 |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
23,742 | $0 | 23,742 (Direct) |
View |
| 2022-05-12 Option Award |
2022-05-16 9:25 pm |
N/A 2032-05-11 |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
20,724 | $0 | 20,724 (Direct) |
View |
| 2022-03-29 Conversion |
2022-03-31 8:15 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
751,621 | $0 | 487,592 (Indirect) |
View |
Ownership |
2022-03-24 9:21 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director |
0 | $0 | 751,621 (Indirect) |
View |